References

  1. ONUSIDA (Programme commun des Nations Unies sur le VIH/SIDA). Rapport sur l’épidémie mondiale de SIDA 2013, 2013. Google Scholar

  2. Gruenais ME, Éd. Un système de santé en mutation : le cas du Cameroun. Association Euro-Africaine pour l’Anthropologie du Changement Social et du Développement. Bulletin de l’APAD N° 21, Paris, 2001. Google Scholar

  3. McCoy D, Chopra M, Loewenson R, Aitken JM, Ngulube T, et al. Expanding access to antiretroviral therapy in sub-saharan Africa: avoiding the pitfalls and dangers, capitalizing on the opportunities. Am J Public Health. 2005; 95 (1) : 18-22. PubMed | Google Scholar

  4. Schneider H, Blaauw D, Gilson L, Chabikuli N, Goudge J. Health systems and access to antiretroviral drugs for HIV in Southern Africa: service delivery and human resources challenges. Reprod Health Matters. 2006; 14 (27): 12-23. PubMed | Google Scholar

  5. Gilks C F, Crowley S, Ekpini R, Gove S, Perriens J, Souteyrand Y, et al. WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet. 2006; 368 (9534): 505-510. PubMed | Google Scholar

  6. Anonyme. Le point sur la stratégie d'accessibilité et de disponibilité des antirétroviraux au Sénégal. Dakar, octobre 1998, 20 p. Google Scholar

  7. Chronologie de l'Initiative Onusida Ministère de la Santé Publique d'accès aux traitements antirétroviraux pour les personnes vivant avec le VIH/sida en Côte-d'Ivoire. ln: Msellati P, Vidal L, Moatti JP (sous la direction de). L'accès aux traitements du VIH/sida en Côte d'Ivoire. Aspects économiques, sociaux et comportementaux. Paris: ANRS, 2000: 63-8S. PubMed | Google Scholar

  8. Coulaud JP (sous la direction de). Initiative internationale: place des antirétroviraux dans la prise en charge des personnes infectées par le VIH en Afrique. Paris: Rapport ANRS-IMEA, 1997: 74 p. Google Scholar

  9. Desclaux A. Évaluation et accompagnement de la multithérapie antirétrovirale chez les patients VIH-l du Sénégal. Aspects sociaux et observance. PNLS Sénégal-ORSTOM-IMEA: Rapport, 1998: 46 p. PubMed | Google Scholar

  10. Seyler C, Anglaret X, Dakoury-Dogbo N, Messou E, Touré S, Danel C, et al. Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire. Antivir Ther. 2003; 8(5): 385-393. PubMed | Google Scholar

  11. Mbopi-Kéou FX, Mpoudi-Ngolle E, Nkengasong J, Zekeng L, Mbanya D, Affana G, et al. Trends of AIDS epidemic in Cameroon, 1986 through 1995. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18 (1): 89-91. PubMed | Google Scholar

  12. Plan stratégique national de lutte contre le VIH/SIDA 2006-2010, Ministère de la Santé Publique du Cameroun, Comité National de Lutte contre le SIDA, Groupe Technique Central. Google Scholar

  13. Eboko F, Abé C, Laurent C. Accès décentralisé au traitement du VIH/sida : Evaluation de l’expérience camerounaise. Sciences sociales et SIDA. ANRS - 29 mars 2010. Google Scholar

  14. Rapport de progrès N° 11-septembre 2008: Vers l’accès universel aux traitements et soins en faveur des adultes et enfants vivant avec le VIH/SIDA au Cameroun. Comité National de Lutte Contre le SIDA. Google Scholar

  15. L’impact du VIH et du sida au Cameroun à l’horizon 2020, Septembre 2010, Comité National de Lutte Contre le SIDA au Cameroun, Groupe Technique Central. Google Scholar

  16. Boyer, S., Blanche J, Marcellin F, Eboko F, Bonono CR, Ongolo-Zogo P, et al. Characteristics and early outcomes of HIV treatment decentralisation in Cameroon: results from the EVAL ANRS 12-116 study. XVII International AIDS Conference, 3-8 August 2008, Mexico City, Mexico. PubMed | Google Scholar

  17. Janssen N, Ndirangu J, Newel M-L, Bland RM. Successful paediatric HIV treatment in rural primary care in Africa. Arch Dis Child. 2010; 95(6): 414-21. PubMed | Google Scholar

  18. Okomo U, Togun T, Oko F, Peterson K, Townend J, Peterson I, Jaye A. Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa. BMC Pediatr. 2012; 12: 95. PubMed | Google Scholar

  19. Peacock-Villada E, Richardson BA, John-Stewart GC. Post-HAART outcomes in pediatric populations: Comparison of resource limited and developed countries. Pediatrics. 2011; 127 (2): e423-e441. PubMed | Google Scholar

  20. Musoke PM, Mudiope P, Barlow-Mosha LN, Ajuna P, Bagenda D, Mubiru MM, Tylleskar T, Fowler MG. Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study. BMC Pediatr. 2010; 10:56. PubMed | Google Scholar

  21. Ahoua L, Guenther G, Rouzioux C, Pinoges L, Anguzu P, Taburet A-M, Balkan S, Olson DM, Olaro C, Pujades-Rodriguez M. Immunovirological response to combines antiretroviral therapy and drug resistance patterns in children: 1- and 2-year outcomes in rural Uganda. BMC Pediatr. 2011; 11:67. PubMed | Google Scholar

  22. Isaakidis P, Raguenaud M-E, Te V, Tray CS, Akao K, Kumar V, Ngin S, Nerrienet E, Zachariah R. High survival and treatment success sustained after two and three years of first line ART for children in Cambodia. J Int AIDS Soc. 2010; 13:11. PubMed | Google Scholar

  23. Edmonds A, Yotebieng M, Lusiama J, Matumona Y, Kitetele F, Napravnik S, Cole SR et al. The effect of highly active antiretroviral therapy on the survival of HIV- infected children in a resource- deprived setting: A cohort study. Plos Med. 2011; 8 (6): e1001044. PubMed | Google Scholar

  24. Reddi A, Leeper SC, Grobler AC, Geddes R, France KH, Dorse GL, Vlok WJ, et al. Preliminary outcomes of paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatrics. 2007; 7:13. PubMed | Google Scholar

  25. Hansudewechakul R, Sirisanthana V, Kurniati N, Puthanakit T, Lumbiganon P, Saphonn V, Yusoff NK, et al. Antiretroviral therapy outcomes of HIV-infected children in the treat Asia pediatric HIV observational database. J Acquir Immune Defic Syndr. 2010; 55(4): 503-509. PubMed | Google Scholar

  26. Van Dijk JH, Sutcliffe CG, Munsanje B, Sinywimaanzi P, Hamangaba F, Thuma PE, Moss WJ. HIV-Infected children in rural Zambia achieve good immunologic and virologic outcomes two years after initiating antiretroviral therapy. Plos One. 2011; 6(4): e19006. PubMed | Google Scholar